Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|October 22, 2025
Mechanism of Inhibition of the MeTC7 Ligand That Covalently Binds to VDR To Reduce PD-L1 ExpressionJérôme Castel, Carole Peluso-Iltis, Angelique Sanchez Dafun, et al.Journal of Circulating Biomarkers|August 21, 2023
Analytical performance of the FDA-cleared Parsortix<sup>®</sup> PC1 systemAmy Templeman, M Craig Miller, Martin J Cooke, et al.Cancers|November 11, 2022
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 SystemEvan N Cohen, Gitanjali Jayachandran, Richard G Moore, et al.Biorxiv : the Preprint Server for Biology|May 18, 2026
IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2John P Miller, Kyu Kwang Kim, Cameron Wa Snyder, et al.Biorxiv : the Preprint Server for Biology|June 22, 2026
Reconstruction of septin higher-order nano-size structures in ovarian cancer cells uncover susceptibility to the septin-targeting small molecule UR214-9Negar Khazan, Cameron Wa Snyder, Nicole Dawney, et al.Journal of Medicinal Chemistry|April 11, 2022
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors <i>In Vivo</i>Negar Khazan, Kyu Kwang Kim, Jeanne N Hansen, et al.Cancers|July 14, 2023
Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1Negar Khazan, Emily R Quarato, Niloy A Singh, et al.Pageof 2